<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03679429</url>
  </required_header>
  <id_info>
    <org_study_id>ADOPTION II</org_study_id>
    <nct_id>NCT03679429</nct_id>
  </id_info>
  <brief_title>NBI Versus White Light Endoscopy for Optical Characterization of Neoplastic Polyps in the Colorectum</brief_title>
  <acronym>ADOPTION II</acronym>
  <official_title>NBI Versus White Light Endoscopy for Optical Characterization of Neoplastic Polyps in the Colorectum - the ADOPTION II Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adenomas, serrated adenomas and hyperplastic polyps are polypoid lesion in the colorectum. At
      the present moment, all polyps should be resected endoscopically, although only adenomas and
      serrated adenomas, but not hyperplastic polyps have the potential to develop colorectal
      cancer. This approach enables the conduction of microscopic investigations of the lesions. By
      today, only the pathological diagnosis can distinguish exactly between these three polyp
      entities. Some studies have investigated the value of the optical characterization approach
      which is based on visual assessment of the polyp' surface structures. Based upon optical
      polyp features users are encouraged to predict histopathological polyp diagnoses solely on
      behalf of optical or endoscopical criteria. This method is conducted in real time during
      colonoscopy. If it could be shown, that endoscopist using the optical characterization
      approach are able to predict histopathological diagnoses of colonic polyps sufficiently this
      would possibly lead to simplification of diagnostic procedures. For instance, it would be
      conceivable to resect small polyps and discard them without further assessment by a
      pathologist. One problem in this context is a correct differentiation between hyperplastic
      polyps and serrated adenomas. These two polyp entities are known to show similar optical
      features. However, while serrated adenomas are premalignant lesions hyperplastic polyps have
      benign histology and never develop into cancer. It is therefore important to sufficiently
      distinguish hyperplastic polyps from serrated lesions.

      In this study we want to investigate whether the use of narrow-band imaging (NBI) would be
      capable to rise accuracy of optical polyp predictions compared to standard HD white light
      endoscopy. NBI is a light filter tool which can be activated by pressing a button at the
      endoscope. The use of NBI leads to an endoscopic picture which appears blue and enables
      endoscopists to better assess surface structures and vascular patterns.

      In a prospective randomised multicenter setting we plan to conduct colonoscopy in 370
      patients. Half of the patients will be examined without the use of NBI (control arm). In
      these cases colonoscopists will assess optical diagnosis of polyps without turning on the NBI
      tool. If polyps are detected in patients belonging to the intervention arm NBI will be used
      and optical diagnosis will be determined using the WASP (Workgroup serrAted polypS and
      Polyposis) classification. All polyps will be resected and send to pathology for further
      microscopic assessment. After completing the trial we aim to compare accuracy of the optical
      diagnosis in both groups. Our hypothesis is, that by using NBI accordance between optical and
      histopathological diagnosis can be increased from 80% to 90%.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2018</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy optical biopsy</measure>
    <time_frame>up to 2 weeks (participants will be followed for the duration of hospital stay or outpatient treatment, an expected average of 2 weeks)</time_frame>
    <description>After obtaining the histopathological diagnosis of resected polyps (approximately 3 days - 2 weeks after colonoscopy ) accuracy of optical diagnosis can be determined</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>up to 2 weeks (participants will be followed for the duration of hospital stay or outpatient treatment, an expected average of 2 weeks)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">370</enrollment>
  <condition>Colon Adenoma</condition>
  <condition>Colorectal Carcinoma</condition>
  <condition>Hyperplastic Polyp</condition>
  <condition>Serrated Adenoma</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Patients from the control group will be examined using a CF-HQ 190 EVIS Exera III Advanced Diagnostic Video Colonoscope. If colon polyps are detected optical diagnosis will be determined WITHOUT using the NBI function of the scope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <description>Patients from the control group will be examined using a CF-HQ 190 EVIS Exera III Advanced Diagnostic Video Colonoscope. If colon polyps are detected optical diagnosis will be determined by using the NBI function of the scope.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NBI Function</intervention_name>
    <description>In the intervention arm polyps will be optically characterized using the NBI function. The WASP (Workgroup serrAted polypS and Polyposis) classification will be used in order to determine the optical diagnosis.</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>NBI Function integrated in the CF-HQ 190 EVIS Exera III Advanced Diagnostic Video Colonoscope</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Colon polyps
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited at the three participating study centers (Munich, Erlangen,
        Stuttgart). Two of the three centers are tertiary referral-centres whereas the last one is
        a major regional hospital. All patients undergo colonoscopy for medical indications.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  medical indication for colonoscopy

          -  age ≥ 40 years

          -  written consent given by patient

        Exclusion Criteria:

          -  age &lt; 40 years

          -  patients denying written consent

          -  pregnant women

          -  ASA class IV, V and VI

          -  known contraindication for polyp resection

          -  indication for colonoscopy: preknown adenoma/polyp/carcinoma or inflammatory bowel
             disease

          -  indication for colonoscopy: emergency (e.g. severe rectal bleeding)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Klare, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum rechts der Isar der Technischen Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roland M Schmid, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Klinikum rechts der Isar der Technischen Universität München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timo Rath, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Erlangen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan Peveling-Oberhag, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Robert Bosch-Krankenhaus Stuttgart</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter Klare, MD</last_name>
    <phone>+49 89 4140 9340</phone>
    <email>peter.klare@.tum.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinik für Innere Medizin II am Klinikum rechts der Isar der Technischen Universität München</name>
      <address>
        <city>Munich</city>
        <state>Bayern</state>
        <zip>81677</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Peter Klare, MD</last_name>
      <phone>+49 89 4140 9340</phone>
      <email>peter.klare@tum.de</email>
    </contact>
    <investigator>
      <last_name>Peter Klare, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen, Medizinische Klinik 1</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Timo Rath, Professor</last_name>
      <email>Timo.Rath@uk-erlangen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Robert-Bosch-Krankenhaus</name>
      <address>
        <city>Stuttgart</city>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Jan Peveling-Oberhag, MD</last_name>
      <email>Jan.Peveling-Oberhag@rbk.de</email>
    </contact>
    <investigator>
      <last_name>Jan Peveling-Oberhag, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 17, 2018</study_first_submitted>
  <study_first_submitted_qc>September 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2018</study_first_posted>
  <last_update_submitted>September 17, 2018</last_update_submitted>
  <last_update_submitted_qc>September 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technische Universität München</investigator_affiliation>
    <investigator_full_name>Peter Klare</investigator_full_name>
    <investigator_title>Dr. med. Peter Klare</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Adenoma detection rate</keyword>
  <keyword>Narrow band imaging</keyword>
  <keyword>Optical biopsy</keyword>
  <keyword>Accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

